Frazier Growth Buyout Adds Glen Moller as Operating Partner

Business Wire

SEATTLE--(BUSINESS WIRE)-- Frazier Healthcare Partners today announced that Glen Moller has been named an Operating Partner on the firm’s Growth Buyout team.

Mr. Moller joins Frazier after a 25-year career leading healthcare and technology businesses. He most recently served as CEO at ArroHealth, one of the nation’s premier risk adjustment and payment integrity companies.

“We are very pleased to have Glen join the Growth Buyout team,” said Frazier general partner Ben Magnano. “His deep leadership experience in healthcare and related technology companies and his consistent record of driving profitable growth in highly competitive markets makes him a perfect fit with our operating model. Adding a veteran talent like Glen enhances our ability to find attractive investment opportunities and we look forward to working with him.”

About Mr. Moller:

From 2011 through 2017, Mr. Moller served as CEO at ArroHealth, which, under his leadership, became one of the nation’s premier risk adjustment and payment integrity companies. The company’s services included population health analytics, mass medical data aggregation, and human- and computer-assisted medical chart analysis. During Mr. Moller’s tenure, the company grew from 40 employees to more than 1,000, and rapidly moved from losses to strong profitability.

Prior to ArroHealth, Mr. Moller headed Centene Corporation’s five-state Medicare business unit, leading a turn-around from a period of continued losses to significant revenue growth and sustained profitability. The company now boasts one of the largest Medicare plans in the country. Before Centene, he was President of Fidelis SecureCare, a growth equity-backed Medicare Institutional Special Needs Plan providing a wholistic care experience and insurance plan for nursing home-eligible enrollees with multiple chronic conditions. Prior to Fidelis, he served as COO of the Express Scripts Insurance Company, where he launched and grew the PBM’s Medicare program, including its national prescription drug plan, now a multi-billion-dollar business and the largest in the U.S. Earlier in his career, Mr. Moller held the position of Chief Marketing Officer at consumer-directed pioneer, HealthMarkets Inc., and at regional operating units of Oxford Health Plans, where he started his career.

Mr. Moller is a board member of 340(b) Technologies and YPO of Long Island and also works with several charities, including an organization mentoring underprivileged high school boys.

He holds dual B.A. degrees from Boston College and an M.B.A. from Harvard Business School.

About Frazier Healthcare Partners:

Founded in 1991, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies. With more than $4.2 billion in total capital raised, Frazier has invested in more than 170 companies with investments ranging from company creation and venture capital to buyouts of profitable lower-middle market companies. The firm’s Growth Buyout team invests in healthcare and pharmaceutical services, medical products and related sectors. The Life Sciences team invests in therapeutics and related areas that are addressing unmet medical needs through innovation. Frazier has offices in Seattle, Wash., and Menlo Park, Calif., and invests broadly across the U.S., Canada and Europe.

For more information about Frazier Healthcare Partners, visit www.frazierhealthcare.com.